LakeShore Biopharma Co. L... (LSB)
undefined
undefined%
At close: undefined
2.50
0.00%
After-hours Dec 13, 2024, 02:44 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue 573.42M 687.20M 502.95M 257.02M
Cost of Revenue 117.69M 153.36M 117.07M 59.66M
Gross Profit 455.73M 533.84M 385.88M 197.36M
Operating Income -445.83M -139.38M -549.18K -125.85M
Interest Income - - - -
Pretax Income -455.19M -144.35M -545.73K -174.37M
Net Income -433.46M -145.48M -545.73K -191.83M
Selling & General & Admin 428.09M 333.32M 549.18K 208.33M
Research & Development 302.80M 318.70M 211.22M 94.39M
Other Expenses 170.67M -199.45K -2.41M -22.36M
Operating Expenses 901.56M 647.15M 549.18K 319.68M
Interest Expense 44.34M 30.86M 2.72M 29.69M
Selling & Marketing Expenses 280.45M 251.56M 165.72M 69.44M
Cost & Expenses 1.02B 800.51M 549.18K 379.33M
Income Tax -21.73M 1.13M 4.94M 17.45M
Shares Outstanding (Basic) 106.92M 77.42M 29.50M 28.75M
Shares Outstanding (Diluted) 106.92M 77.42M 29.50M 28.75M
EPS (Basic) -4.05 -1.88 -0.02 -6.67
EPS (Diluted) -4.05 -1.88 -0.02 -6.67
EBITDA -368.66M -76.80M -67.20M -116.78M
Depreciation & Amortization 42.19M 36.69M 31.15M 27.91M